West Pharmaceutical Services, Inc. WST
- Market cap
- $26.3B
- P/E
- 47.1×
Follow WST
West Pharmaceutical Services, Inc. (WST) Return on invested capital
West Pharmaceutical Services, Inc.'s return on invested capital over the twelve months to 30 June 2026 was 15.4%, up 1.3 percentage points from fiscal 2025 (14.1%). Over the past ten years it has ranged from 8.22% (fiscal 2015) to 26.4% (fiscal 2021); the current reading is higher than 55% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Annual
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 14.1% | (0.71) |
| FY2024 | 14.8% | (5.28) |
| FY2023 | 20.1% | (2.85) |
| FY2022 | 23.0% | (3.42) |
| FY2021 | 26.4% | 9.34 |
| FY2020 | 17.1% | 3.71 |
| FY2019 | 13.3% | 1.37 |
| FY2018 | 12.0% | 0.60 |
| FY2017 | 11.4% | 0.67 |
| FY2016 | 10.7% | 2.48 |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| RMD ResMed Inc. compare | 21.4% |
| MDLN Medline Inc. compare | 19.9% |
| WST West Pharmaceutical Services, Inc. | 15.4% |
| SOLV Solventum Corporation compare | 13.4% |
| BDX Becton, Dickinson and Company compare | 3.89% |
| COO The Cooper Companies, Inc. compare | 3.17% |
| ALC Alcon compare | 2.38% |
| RGEN Repligen Corporation compare | 2.18% |
| BAX Baxter International Inc. compare | −1.27% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on WST
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement